C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice
- PMID: 28044935
- DOI: 10.2174/1871520617666170103101844
C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice
Abstract
Background: C-glycosyl flavone, a phytochemical constituent in U.indica bulb, has been reported to possess cytotoxic activity.
Objective: The present study aims to investigate the toxicity and anticancer potentials of C-glycosyl flavone against Ehrlich ascites carcinoma mice model.
Method: In present study, acute and chronic toxicity along with antitumor activity of C-glycosyl flavone isolated from U.indica bulb were Performed using in vitro and in vivo methods. Acute and chronic toxicity of C-glycosyl flavone was evaluated using Swiss albino mice. The effect of C-glycosyl flavone on proliferation of Ehrlich ascites carcinoma (EAC) cells was determined. Further, growth inhibition and dissemination were studied using EAC induced mice model.
Results: C-glycosyl flavone showed significant therapeutic potency against EAC cells in terms of reduced viability, cell cycle arrest, induction of apoptosis, inhibition of capillary formation, reduced VEGF levels. Moreover, there was reduction in body weight, tumor volume, viable tumor cells, increased survival of EAC induced mice upon C-glycosyl flavone treatment. Treatment also reduced dissemination of EAC cells into heart, kidney, liver and brain and diminished the pathological alterations induced by EAC cells in mice. In addition, there was an improvement in hemoglobin levels and counts of RBC, neutrophils, lymphocytes and monocytes in C-glycosyl flavone-treated mice with tumor. An enhancement of antioxidant status in C-glycosyl flavone treated EAC-bearing mice which appeared in terms of decreased serum thiobarbituric acid reactive substance and lipid peroxidation, increased GSH, SOD, Catalase and GPX. These results were comparable to a standard 5- fluorouracil treatment. C-glycosyl flavone exhibited safety profile in toxicity studies.
Conclusion: Our study confirms the therapeutic potency of C-glycosyl flavone against EAC in inhibition of dissemination and growth of EAC in mice.
Keywords: C-glycosyl flavone; Ehrlich ascites carcinoma; antioxidant enzymes; antitumor activity; histopathology..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
C-glycosyl flavone from Urginea indica inhibits proliferation & angiogenesis & induces apoptosis via cyclin-dependent kinase 6 in human breast, hepatic & colon cancer cell lines.Indian J Med Res. 2018 Feb;147(2):158-168. doi: 10.4103/ijmr.IJMR_51_16. Indian J Med Res. 2018. PMID: 29806604 Free PMC article.
-
Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].Acta Pharmacol Sin. 2004 Aug;25(8):1070-6. Acta Pharmacol Sin. 2004. PMID: 15301742
-
Evaluation of anticancer activity of ethanol extract of Sesbania grandiflora (Agati Sesban) against Ehrlich ascites carcinoma in Swiss albino mice.J Ethnopharmacol. 2011 Apr 12;134(3):984-7. doi: 10.1016/j.jep.2011.01.012. Epub 2011 Jan 18. J Ethnopharmacol. 2011. PMID: 21251969
-
Effectors and signaling events activated by cell shrinkage in ehrlich ascites tumor cells: implications for cell proliferation and programmed cell death.Adv Exp Med Biol. 2004;559:169-78. doi: 10.1007/0-387-23752-6_16. Adv Exp Med Biol. 2004. PMID: 18727238 Review. No abstract available.
-
Tumor-specific blood serum factors as determinants of tumor growth.Klin Lab Diagn. 2013 Oct;(10):50-2, 13-5. Klin Lab Diagn. 2013. PMID: 24640094 Review. English, Russian.
Cited by
-
Combination of ionizing radiation and 2-thio-6-azauridine induces cell death in radioresistant triple negative breast cancer cells by downregulating CD151 expression.Cancer Chemother Pharmacol. 2024 Nov;94(5):685-706. doi: 10.1007/s00280-024-04709-w. Epub 2024 Aug 21. Cancer Chemother Pharmacol. 2024. PMID: 39167147
-
Bulbous Plants Drimia: "A Thin Line between Poisonous and Healing Compounds" with Biological Activities.Pharmaceutics. 2021 Sep 1;13(9):1385. doi: 10.3390/pharmaceutics13091385. Pharmaceutics. 2021. PMID: 34575461 Free PMC article. Review.
-
Drimia indica: A Plant Used in Traditional Medicine and Its Potential for Clinical Uses.Medicina (Kaunas). 2019 Jun 7;55(6):255. doi: 10.3390/medicina55060255. Medicina (Kaunas). 2019. PMID: 31181697 Free PMC article. Review.
-
Antitumor Activity of Bioactive Compounds from Rapana venosa against Human Breast Cell Lines.Pharmaceuticals (Basel). 2023 Jan 24;16(2):181. doi: 10.3390/ph16020181. Pharmaceuticals (Basel). 2023. PMID: 37259331 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources